Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) is integrating its NeuroStar TMS practice-management technology with AdvancedMD’s electronic health record and revenue-cycle platform, creating what the company describes as the first …
Neuronetics Links NeuroStar TMS With AdvancedMD Platform Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) reached an understanding with its second-largest shareholder, Jorey Chernett, that could give him a role in shaping the medical technology company’s board while …
Neuronetics Opens Board Path for Second-Largest Shareholder Read More MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) granted inducement equity awards to five newly hired non-executive employees under Nasdaq Listing Rule 5635(c)(4), using stock-based incentives to support recruitment outside its …
Neuronetics Grants Equity Awards to Five New Employees Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has opened a new Greenbrook Mental Wellness Centers facility in Rockville, Maryland, expanding its footprint in interventional psychiatry while establishing a flagship site …
Neuronetics Opens Maryland Mental Health Hub Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) plans to report its second-quarter 2026 financial and operating results before U.S. markets open on Aug. 11, with management scheduled to discuss the …
Neuronetics to Report Second-Quarter Results on Aug. 11 Read More MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) appointed Nir Naor as chief financial officer on July 23 as the medical technology company reshapes its leadership around balance-sheet discipline and expansion …
Neuronetics Names CFO as Greenbrook Leadership Shifts Read More MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) will participate in an institutional investor conference next week, providing investors with an opportunity to hear the company’s perspective on the commercialization of …
Neuronetics Joins Investor Summit as Mental Health Market Evolves Read More MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) has appointed healthcare sales executive Robert Greene as senior vice president of sales and awarded him restricted stock units valued at 200,000 shares, …
Neuronetics Names Sales Chief, Grants Equity Incentive Read More MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) has partnered with ANT Neuro to integrate image-guided neuronavigation technology into its NeuroStar transcranial magnetic stimulation platform, as providers increasingly seek more personalized …
Neuronetics Expands NeuroStar With Navigation Partnership Read More MALVERN, PA — Neuronetics (NASDAQ: STIM) reported higher first-quarter revenue driven by growth in its U.S. clinic operations following the Greenbrook acquisition, while the company narrowed losses and reduced cash …
Neuronetics Revenue Rises as Clinic Business Expands Read More